RBC Capital Downgrades Outset Medical to Sector Perform, Lowers Price Target to $6
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has downgraded Outset Medical (NASDAQ:OM) from Outperform to Sector Perform and reduced the price target from $14 to $6.
January 12, 2024 | 11:20 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Outset Medical's stock rating was downgraded by RBC Capital from Outperform to Sector Perform, and the price target was cut from $14 to $6.
Analyst downgrades typically lead to a negative perception of the company's future performance and can result in a decrease in stock price. The substantial reduction in price target from $14 to $6 suggests a significant revision of the company's expected performance, which could lead to a short-term decline in Outset Medical's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100